Cargando…

Identification and Validation of Three Hub Genes Involved in Cell Proliferation and Prognosis of Castration-Resistant Prostate Cancer

BACKGROUND: The acquisition of castration resistance is lethal and inevitable in most prostate cancer patients under hormone therapy. However, effective biomarkers and therapeutic targets for castration-resistant prostate cancer remain to be defined. METHODS: Comprehensive bioinformatics tools were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Pan, Dai, Yibei, Zhuang, Tingting, Yue, Xiaofang, Chen, Yuhua, Wang, Xuchu, Duan, Xiuzhi, Ping, Ying, Xie, Yiyi, Cao, Ying, Tao, Zhihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402298/ https://www.ncbi.nlm.nih.gov/pubmed/36035209 http://dx.doi.org/10.1155/2022/8761112

Ejemplares similares

SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
por: Liu, Weiwei, et al.
Publicado: (2018)

Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
por: Zhang, Lingyu, et al.
Publicado: (2021)

How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
por: Duan, Xiuzhi, et al.
Publicado: (2023)

SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway
por: Liu, Weiwei, et al.
Publicado: (2017)

Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma
por: Zhang, Lingyu, et al.
Publicado: (2021)

The rs9402373 polymorphism of CTGF gene may not be related to inflammatory bowel disease susceptibility in Chinese population based on ARMS-PCR genotyping
por: Xie, Yiyi, et al.
Publicado: (2023)

Comprehensive analysis of fifteen hub genes to identify a promising diagnostic model, regulated networks, and immune cell infiltration in acute kidney injury
por: Sun, Tao, et al.
Publicado: (2022)

Prostatic aspirated cellular RNA analysis enables fast diagnosis and staging of prostate cancer
por: Sang, Yiwen, et al.
Publicado: (2020)

Circulating tumor cells in prostate cancer: Precision diagnosis and therapy
por: Liu, Weiwei, et al.
Publicado: (2017)

A quantitative detection of Cardiotrophin‐1 in chronic heart failure by chemiluminescence immunoassay
por: Ping, Ying, et al.
Publicado: (2021)

Machine Learning Reveals a Multipredictor Nomogram for Diagnosing the Alzheimer’s Disease Based on Chemiluminescence Immunoassay for Total Tau in Plasma
por: Zhang, Lingyu, et al.
Publicado: (2022)

A Multivariate Diagnostic Model Based on Urinary EpCAM-CD9-Positive Extracellular Vesicles for Prostate Cancer Diagnosis
por: Dai, Yibei, et al.
Publicado: (2021)

RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells
por: Yin, Binbin, et al.
Publicado: (2017)

RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells
por: Yin, Binbin, et al.
Publicado: (2022)

Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase
por: Yu, Pan, et al.
Publicado: (2017)

Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients
por: Sun, Tao, et al.
Publicado: (2019)

The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy
por: Duan, Xiuzhi, et al.
Publicado: (2019)

Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling
por: Wang, Weixi, et al.
Publicado: (2023)

Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment
por: Muniyan, Sakthivel, et al.
Publicado: (2022)

Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancer
por: Zhou, Yang-Yang, et al.
Publicado: (2019)

Emerging proteins involved in castration-resistant prostate cancer via the AR-dependent and AR-independent pathways (Review)
por: Feng, Kangle, et al.
Publicado: (2023)

Identification of castration‐resistant prostate cancer‐related hub genes using weighted gene co‐expression network analysis
por: Cheng, Yifei, et al.
Publicado: (2020)

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer
por: Bremmer, Felix, et al.
Publicado: (2018)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Bone marrow involvement in patients with metastatic castration sensitive prostate cancer
por: Shahait, Mohammed, et al.
Publicado: (2022)

Serum Chromogranin-A based Prognosis In Metastatic Castration Resistant Prostate Cancer
por: Giridhar, Karthik V., et al.
Publicado: (2018)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancer
por: Pan, Jian, et al.
Publicado: (2022)

Castration for Hypertrophy of the Prostate Gland
Publicado: (1895)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao, Ying, et al.
Publicado: (2021)

Combination of C-reactive protein/albumin ratio and time to castration resistance enhances prediction of prognosis for patients with metastatic castration-resistant prostate cancer
por: Mitsui, Yozo, et al.
Publicado: (2023)

The Role of Androgen Receptor Splicing Variant 7 in Predicting the Prognosis of Metastatic Castration-Resistant Prostate Cancer: Systematic Review and Meta-Analysis
por: Liu, Rui-Ji, et al.
Publicado: (2021)

Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation
por: Iuliani, Michele, et al.
Publicado: (2022)

Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis
por: Tian, Aiping, et al.
Publicado: (2019)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

A Case of Castration for Hypertrophied Prostate
Publicado: (1897)

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
por: Wu, Junlong, et al.
Publicado: (2017)

Conjoint analysis for hepatic carcinoma with hub genes and multi-slice spiral CT
por: Zhang, Shuang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_39ko20168sbne38c9rqf6uegat